Pioneering Pharmaceuticals

Making pharmaceuticals more affordable, more available, and better than before

Innovative solutions along the entire pharmaceutical value chain
As part of the TIEFENBACHER GROUP, a 100% family-owned leading health care company, we provide solutions throughout the entire life cycle of a pharmaceutical product. We develop, manufacture, and register innovative as well as generic drugs for our B2B customers. The world´s most trusted brands count on our high excellence in creating best-in-class-dossiers and our ability to manage complex launches in over 80 countries worldwide. Our own laboratories and manufacturing sites empower us to build up efficient supply chains resulting in best value for money for our customers.
There is one purpose driving TIEFENBACHER´s over 600 employees day by day: improving the life of millions of patients worldwide by making pharmaceuticals more affordable, more available, and better than before.

Driving force for advanced medicines

The numbers speak for us

>500million

patients served every year

600+

employees worldwide

180+

dossiers developed/ under development

40+

projects in pipeline

>500million

patients served every year

~600

employees worldwide

100+

dossiers developed

40+

development projects running

>3billion

units inhouse production capacity per year

15.000+

marketing authorizations obtained

80+

different countries where products are being sold

150+

active customers on five continents

~3bn

units production capacity per year

15.000+

marketing authorizations obtained

80+

different countries where products are being sold

150+

active customers on five continents

AET: Specialized in the Development and Commercialization of pharmaceuticals

Our purpose - Care for patients´ health by offering:

Better Affordability

of high-quality medicines

Read more

Better Availability

Throughout the world

Read more

Better Therapy

for patients

Read more

Better Affordability

Advancing Healthcare

Read more

Better Global Availability

Boosting Medicines

Read more

Better Therapy

CreatingValue

Read more

We are TIEFENBACHER GROUP

News

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Swedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new innovative development projects targeting ADHD, rare diseases, and transplantation…

Read More

Spreading of Post COVID-19 Disease „Black Fungus“ in India – TIEFENBACHER GROUP supports with Posaconazole Tablets

Black Fungus (Mucormycosis) is dramatically spreading in India connected to the extensive 2nd COVID-19 wave. The highly life-threatening disease usually occurs as a rare disease in immunocompromised…

Read More

GLOBAL PRESENCE AROUND THE WORLD

Our path to profitable growth: Creating breakthrough pharmaceuticals worldwide I more affordable, more available, and better than before

Contact – Partner with us

As the builders of the future, we´re working to improve patients´ lives. By thinking beyond healthcare.




    ALFRED E. TIEFENBACHER (GmbH & Co. KG)
    Van-der-Smissen-Strasse 1
    22767 Hamburg
    Germany

    Phone: +49 40 – 44 18 09 – 0
    Fax: +49 40 – 44 18 09 – 26
    Mail: info@aet.eu